Related Experiment Video
Updated: Jun 17, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Transfusion and clinical outcomes after percutaneous coronary intervention
Jungmin Choi1, Seung-Hwa Lee2, Ki-Hong Choi2
1Department of Digital Health, Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Blood transfusions after percutaneous coronary intervention (PCI) are common and increase the risk of major adverse clinical events (MACE). Patients receiving transfusions had a 3.2-fold higher MACE risk within five years post-PCI.
Area of Science:
- Cardiology
- Transfusion Medicine
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
- The role and impact of blood transfusions on long-term outcomes following PCI require further investigation.
Purpose of the Study:
- To investigate the long-term patterns and clinical outcomes associated with blood transfusions in patients undergoing PCI.
- To assess the association between transfusion and major adverse clinical events (MACE) after PCI.
Main Methods:
- Analysis of a nationwide registry of Korean patients undergoing PCI with stenting in 2011 (n=48,786).
- Evaluation of 5-year clinical outcomes, focusing on the incidence density of transfusion.
- Propensity score adjustment to assess the association of transfusion with MACE (all-cause death, revascularization, critical cardiovascular status, stroke).
Main Results:
- The 5-year incidence density of transfusion was 4.74 per 100 person-years.
- Transfused patients were older with more clinical risk factors (p<0.001).
- Transfusion was significantly associated with increased MACE (HR 3.2) and other clinical events (HR 1.5-6.9, p<0.001).
- Within 5 years, 22.9% of patients received transfusions, experiencing a 3.2-fold higher MACE risk.
Conclusions:
- Blood transfusion after PCI is associated with a significantly higher risk of major adverse clinical events.
- The timing of transfusion correlates with periods of highest MACE incidence density.
- These findings highlight the importance of judicious transfusion strategies in PCI patients.
More Related Videos
06:25Author Spotlight: Innovative Technique for Coronary Angiography in Marginal Donors
Published on: July 12, 2024
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...